KR20060076775A - 인간 β-디펜신 분비 촉진제 - Google Patents

인간 β-디펜신 분비 촉진제 Download PDF

Info

Publication number
KR20060076775A
KR20060076775A KR1020067005330A KR20067005330A KR20060076775A KR 20060076775 A KR20060076775 A KR 20060076775A KR 1020067005330 A KR1020067005330 A KR 1020067005330A KR 20067005330 A KR20067005330 A KR 20067005330A KR 20060076775 A KR20060076775 A KR 20060076775A
Authority
KR
South Korea
Prior art keywords
human
acid
defensin
secretion
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067005330A
Other languages
English (en)
Korean (ko)
Inventor
사치요 이가라시
히데오 다나카
오사무 다카스
시게오 시노하라
마사히코 다나카
미사토 야고
Original Assignee
오츠카 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오츠카 세이야쿠 가부시키가이샤 filed Critical 오츠카 세이야쿠 가부시키가이샤
Publication of KR20060076775A publication Critical patent/KR20060076775A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
KR1020067005330A 2003-09-19 2004-09-17 인간 β-디펜신 분비 촉진제 Ceased KR20060076775A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP-P-2003-00328704 2003-09-19
JP2003328704 2003-09-19

Publications (1)

Publication Number Publication Date
KR20060076775A true KR20060076775A (ko) 2006-07-04

Family

ID=34372909

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067005330A Ceased KR20060076775A (ko) 2003-09-19 2004-09-17 인간 β-디펜신 분비 촉진제

Country Status (10)

Country Link
US (1) US20070093416A1 (https=)
EP (1) EP1671629A4 (https=)
JP (1) JP4847756B2 (https=)
KR (1) KR20060076775A (https=)
CN (1) CN1852708B (https=)
AU (1) AU2004273738B2 (https=)
BR (1) BRPI0414543A (https=)
CA (1) CA2538760A1 (https=)
TW (1) TW200524585A (https=)
WO (1) WO2005027893A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012026639A1 (ko) 2010-08-27 2012-03-01 (주)네오팜 인간유래 항균 펩타이드의 분비를 촉진하는 신규화합물, 그 제조방법 및 이를 유효성분으로 함유하는 조성물
KR101489638B1 (ko) * 2008-04-01 2015-02-11 (주)네오팜 인간유래 항균 펩타이드의 분비를 촉진하는 신규화합물, 그제조방법, 및 이를 유효성분으로 함유하는피부외용제조성물
KR20180059296A (ko) * 2016-11-25 2018-06-04 (주)모아캠 가자 추출물 및 애엽 추출물을 함유하는 피부세균총의 생장 조절 또는 피부 면역 강화용 조성물

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5419451B2 (ja) 2006-06-28 2014-02-19 アース製薬株式会社 歯のエナメル質の溶解阻害剤
WO2008096730A1 (ja) * 2007-02-09 2008-08-14 National University Corporation Nagoya University 抗炎症剤及びその用途
JP2009007323A (ja) * 2007-05-29 2009-01-15 Earth Chem Corp Ltd ウイルス不活化剤、ウイルス感染予防方法及びそのウイルス不活化剤をも収納し得る容器
JP5511183B2 (ja) * 2007-12-28 2014-06-04 アース製薬株式会社 有機酸による歯のエナメル質の溶解が阻害される口腔用組成物
US8076088B2 (en) * 2008-02-22 2011-12-13 Case Western Reserve University Method of detecting human β-defensins
CN101591672B (zh) * 2009-05-22 2011-09-07 西北农林科技大学 一种包含hBD3乳腺特异性表达载体的重组牛胎儿成纤维细胞
GB0920846D0 (en) 2009-11-27 2010-01-13 Croda Int Plc Defenin inducing agent
WO2011130646A1 (en) 2010-04-15 2011-10-20 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
KR101249702B1 (ko) 2010-06-16 2013-04-05 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
NZ732118A (en) 2011-04-15 2018-11-30 Marine Polymer Tech Inc Treatment of disease with poly-n-acetylglucosamine nanofibers
SG10201602399SA (en) * 2011-09-27 2016-05-30 Santen Pharmaceutical Co Ltd Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
US9532946B2 (en) 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
JP6222217B2 (ja) * 2013-02-14 2017-11-01 ライオン株式会社 口腔用組成物
JP6209062B2 (ja) * 2013-11-12 2017-10-04 株式会社ファンケル 抗菌性ペプチドの分泌促進剤
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3435765A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
CN109152754A (zh) * 2016-05-17 2019-01-04 拥护者生物技术有限公司 用于治疗/预防鼻充血的羧酸
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CN107918010A (zh) * 2017-11-27 2018-04-17 陕西科技大学 一种高灵敏液晶型非标记免疫传感器检测人类β防御素‑2的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58009A (en) * 1978-08-14 1982-11-30 Sterling Drug Inc Process and compositions comprising glutaric acid for neutralizing or destroying viruses
JPH03294227A (ja) * 1990-04-13 1991-12-25 Dai Ichi Seiyaku Co Ltd 口腔用組成物
AU1271592A (en) * 1991-01-18 1992-08-27 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5260083A (en) * 1992-03-25 1993-11-09 The J. M. Smucker Company Fruit spread and method of preparing same
JP3207523B2 (ja) * 1992-06-19 2001-09-10 明治乳業株式会社 肝障害患者に有効な組成物
CN1033421C (zh) * 1992-12-09 1996-12-04 何名富 一种药物牙膏的制备方法
US5830487A (en) * 1996-06-05 1998-11-03 The Procter & Gamble Company Anti-viral, anhydrous, and mild skin lotions for application to tissue paper products
DE4439858A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Durch Co-Sprühtrocknung erhältliche Polyol-Zusammensetzung
JP3241955B2 (ja) * 1994-12-26 2001-12-25 花王株式会社 口腔用組成物
WO1996026707A1 (en) * 1995-02-28 1996-09-06 U.S. Meds - Bulgaria Ltd. Composition for hygiene, prophylaxis and treatment of the oral cavity
CN1229641A (zh) * 1998-03-20 1999-09-29 湖北医科大学附属第二医院 假牙清洁剂
US6469066B1 (en) * 1998-12-18 2002-10-22 Palladin Healthcare International, Ltd. Composition for pain mediation and apparatus and method of use thereof
JP2001089385A (ja) * 1999-09-22 2001-04-03 Kobayashi Pharmaceut Co Ltd 抗う蝕剤
CA2382985A1 (en) * 1999-10-19 2001-04-26 Jeffrey Michael Morgan Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts
AU2001245726A1 (en) * 2000-03-15 2001-09-24 Genaera Corporation A method for stimulation of defensin production
JP2002114704A (ja) * 2000-09-29 2002-04-16 Morinaga & Co Ltd 抗菌剤
JP2003000262A (ja) * 2001-06-22 2003-01-07 Morinaga & Co Ltd ほ乳類抗菌ペプチドの発現誘導及び／又は増強組成物、該組成物を含有する飲食品、医薬品及び医薬部外品
JP2003116486A (ja) * 2001-08-09 2003-04-22 Meiji Milk Prod Co Ltd 食後の血糖上昇抑制作用を有する食品組成物
JP2003095938A (ja) * 2001-09-21 2003-04-03 Masami Moriyama 抗菌ペプチド分泌誘発剤
US20040063123A1 (en) * 2002-03-05 2004-04-01 Yoshihiro Abiko Method of collecting data for estimation of susceptibility to periodontal disease
FR2843125B1 (fr) * 2002-08-02 2012-11-16 Coletica Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs
JP4554150B2 (ja) * 2002-11-28 2010-09-29 雅美 森山 薬剤耐性菌による感染症治療剤
JP4683844B2 (ja) * 2003-02-10 2011-05-18 雅美 森山 インフルエンザウイルス感染予防剤
US7041311B2 (en) * 2003-02-28 2006-05-09 International Flavors & Fragrances Inc. Preparation for saliva flow

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101489638B1 (ko) * 2008-04-01 2015-02-11 (주)네오팜 인간유래 항균 펩타이드의 분비를 촉진하는 신규화합물, 그제조방법, 및 이를 유효성분으로 함유하는피부외용제조성물
WO2012026639A1 (ko) 2010-08-27 2012-03-01 (주)네오팜 인간유래 항균 펩타이드의 분비를 촉진하는 신규화합물, 그 제조방법 및 이를 유효성분으로 함유하는 조성물
KR20180059296A (ko) * 2016-11-25 2018-06-04 (주)모아캠 가자 추출물 및 애엽 추출물을 함유하는 피부세균총의 생장 조절 또는 피부 면역 강화용 조성물

Also Published As

Publication number Publication date
JP4847756B2 (ja) 2011-12-28
EP1671629A4 (en) 2008-11-26
CA2538760A1 (en) 2005-03-31
EP1671629A1 (en) 2006-06-21
HK1092057A1 (en) 2007-02-02
TW200524585A (en) 2005-08-01
JPWO2005027893A1 (ja) 2006-11-24
WO2005027893A1 (ja) 2005-03-31
AU2004273738B2 (en) 2011-02-03
AU2004273738A1 (en) 2005-03-31
CN1852708B (zh) 2010-09-22
BRPI0414543A (pt) 2006-11-07
CN1852708A (zh) 2006-10-25
TWI342773B (https=) 2011-06-01
US20070093416A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
JP4847756B2 (ja) ヒトβディフェンシン分泌促進剤
US20230241165A1 (en) Mannose-binding lectin for treatment or prophylaxis of infectious diseases
US20040214750A1 (en) Medicaments for healing skin conditions in humans
JP2025535179A (ja) カンナビジオール及びタウリンを含む歯周炎の予防又は治療用組成物
JP2000103743A (ja) チオレドキシン活性を有するファミリーに属するポリペプチド類を含有する食品、化粧品及び医薬
JP6600124B2 (ja) 菓子
WO2023282283A1 (ja) 口腔環境改善用組成物
ES2674874T3 (es) Composición antiinflamatoria
JP5511183B2 (ja) 有機酸による歯のエナメル質の溶解が阻害される口腔用組成物
US11759435B2 (en) Dihydrochalcone derivatives influencing inflammatory states
KR20230120619A (ko) 피부 상태 개선용 조성물
KR20180046244A (ko) 코디세핀을 포함하는 구강질환 예방 또는 치료용 조성물
JPH08133983A (ja) アスパラス・リネアリス抽出物及び用途
HK1092057B (en) HUMAN β-DEFENSIN SECRETION PROMOTER
JP3560424B2 (ja) 抗菌性組成物
CA3139470C (en) A composition enabling the prevention or treatment of asthma, rhinitis, or conjunctivitis, comprising N-acylamine acid as the active ingredient.
JP7789515B2 (ja) 糖化抑制剤
JP6871760B2 (ja) 抗ウイルス作用促進用組成物
KR20230123915A (ko) 항염증제
JP2021095358A (ja) Ａｇｒ２発現促進剤
WO2003006072A1 (en) A method of treatment and/or prophylaxis of ulcers
US20090209486A1 (en) Compositions of carbohydrates as dietary supplements
KR20170117369A (ko) 협설측 질환 치료용 피막 형성 조성물 및 이의 용도
JP2025030881A (ja) ミトコンドリア活性化用組成物
WO2006003750A1 (ja) 炎症予防・抗炎症剤、医薬品、飲食品及び香粧品

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060316

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20090907

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110529

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20111227

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20110529

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I